Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

NCT00168298 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00168298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
November 1, 2004
Completion date
September 5, 2008
Enrollment
668 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, retinal vein occlusion